Catch up on global daily news
Compelling long reads
Tune into captivating conversations
Watch engaging short films
Behind the scenes at The Economist
Couples should be allowed to select embryos on the basis of both disease resistance and IQ
Silicon Valley startups commercialize embryo screening for IVF, assessing genetic disease risk and scoring IQ, height, physical traits. This biotech-AI convergence creates M&A and funding opportunities but requires regulatory clarity and governance frameworks to enable enterprise adoption.
Catch up on global daily news
Compelling long reads
Tune into captivating conversations
Watch engaging short films
Behind the scenes at The Economist

Startups claim they can screen embryos for everything from genetic diseases to IQ. Not everyone is convinced

Widespread bans don’t seem to be a hindrance

Our podcast on markets, the economy and business. This week, the business of getting pregnant

A handpicked article read aloud from the latest issue of The Economist

Our podcast on science and technology. Our correspondent weighs up the benefits and risks of newborn screening programmes

A handpicked article read aloud from the latest issue of The Economist